![Loading Events](https://pharmajournalist.com/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
- This event has passed.
2nd Annual mRNA-Based Therapeutics Summit
July 26, 2022 - July 28, 2022
Do you want to be part of the largest gathering of mRNA professionals?
The 2nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28.
Expect exclusive data from the movers and shakers in mRNA vaccine and therapy development, 75+ world-class speakers, 5 dedicated tracks of content and 45+ deep-dive case studies. Find out more in the full event guide: https://ter.li/yc800m
Here’s a snapshot of the expert speakers you can hear from:
- Kathy Fernando, VP, Head of Worldwide Research, Development and Medical Operations & Head of mRNA Scientific Planning, Pfizer
- Regis Gervier, Global Head, mRNA Center of Excellence, Sanofi
- Rituparna Das, VP – COVID Vaccines, Moderna
- Hao Chen, Global Head of Cell & Viral Drug Substance, GlaxoSmithKline
- Joe Payne, Founder, President & CEO, Arcturus Therapeutics
- Pervin Anklesaria, Deputy Director, HIV Vaccines & Biologics, Bill & Melinda Gates Foundation
- Manmohan Singh, SVP – Pharmaceutical Sciences & Delivery Technologies, Beam Therapeutics
- Akhilesh Bhambhani, Senior Director – Biologics Drug Product Development; Tech Dev/Tech Ops, Ultragenyx
- Liang Shang, Senior Scientist – Vaccine Analytical, Merck
- Russell Johnson, VP – Formulation Research, RVAC Medicines
- Tamar Grossman, Global Head – RNA & Targeted Therapeutics, The Janssen Pharmaceutical Companies of Johnson & Johnson
Download the official brochure to discover why Sanofi, Ultragenyx, Beam Therapeutics, Pfizer, Moderna, Merck, Eli Lilly, GSK, and 300+ others have already secured their places. https://ter.li/yc800m